Delivery Order SPE2DB20D1100-SPE2DB24FD2K0
Award Date
8/13/24
Potential Completion Date
8/14/24
Potential Value
$14K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,027.60, is for the delivery of ONTRUZANT 150 MG VIALS, a medical product. The contract has a firm fixed price pricing type and a completion date of March 4, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,676.83, is for the supply of ONTRUZANT 420 MG VIALS, a medical product. The contract has an ultimate completion date of January 8, 2025 and is a firm fixed-price delivery order. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,676.48, is for the supply of 4566842976 ONTRUZANT 420 MG VIALS. It is a firm fixed-price delivery order contract, with a period of performance through January 7, 2025. The contract was not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,080.33, is for the delivery of ONTRUZANT 150 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of June 25, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $27,236.77, is for the delivery of ONTRUZANT 420 MG VIALS medical products. The contract has an ultimate completion date of February 21, 2024 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,437.80 fixed-price delivery order is for the supply of ONTRUZANT 150 MG VIALS, a medical product, with an ultimate completion date of June 4, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order (DO) valued at $42,275.51 with a firm fixed price pricing type. The contract is for the supply of the drug product ONTRUZANT 150 MG VIALS, with a period of performance through May 14, 2024. This contract award is not designated as a set-aside. AmerisourceBergen holds a...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution and services company. The contract is for the delivery of 150 mg vials of the pharmaceutical product ONTRUZANT, with a ceiling value of $16,458.59 and a completion date of April 9, 2024. AmerisourceBergen Drug Corp is the prime contractor for this award,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,991.32 firm-fixed-price delivery order is for the supply of ONTRUZANT 420 MG VIALS. The contract has a period of performance through March 5, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $62,776.72 contract is for the delivery of 4,565,631,436 vials of the pharmaceutical product ONTRUZANT 420 MG. The order has an ultimate completion date of August 30, 2024. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the federal government, was awarded this delivery order through the company's Indefinite...